BioCentury | Aug 5, 2019
Clinical News
Aug. 5 Clinical Quick Takes: Emgality meets for migraine with treatment failures; plus Verona, Alkahest-Grifols, Squarex and Denali-Sanofi
...Madrid:GRF;NASDAQ:GRFS), also met its primary safety and tolerability endpoint. Squarex's cold sore therapy suppresses outbreaks Squarex LLC...
...Staff Writer AKST6019 (GRF6019, ALK6019) DNL758 Emgality, galcanezumab-gnlm (LY2951742) ensifentrine (RPL554, VMX554, VRP554) SQX770 Alkahest Inc. Denali Therapeutics Inc. Eli Lilly and Co. Grifols S.A. Sanofi Squarex LLC Verona...
...Staff Writer AKST6019 (GRF6019, ALK6019) DNL758 Emgality, galcanezumab-gnlm (LY2951742) ensifentrine (RPL554, VMX554, VRP554) SQX770 Alkahest Inc. Denali Therapeutics Inc. Eli Lilly and Co. Grifols S.A. Sanofi Squarex LLC Verona...